The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease (Q70871873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

A. J. McCullough

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262510

4 April 2024

A. J. Czaja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262510

4 April 2024

J. D. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262510

4 April 2024

V. L. Go

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7262510

4 April 2024

language of work or name

English

0 references

publication date

1 October 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 October 2019

https://api.elsevier.com/content/article/PII:0016508581904868?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

https://api.elsevier.com/content/article/PII:0016508581904868?httpAccept=text/plain

4 April 2024

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

4 April 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

645-652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7262510%20AND%20SRC:MED&resulttype=core&format=json

Amino acid and α-keto acid concentrations in plasma and blood of the liverless dog

14 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Pathogenesis of Hepatic Coma

4 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Hepatic encephalopathy: summary of present knowledge with an elaboration on recent developments

4 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acids in dogs with two experimental forms of liver damage

4 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy

4 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Insulin, plasma aminoacid imbalance, and hepatic coma

4 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Hepatic metabolism in patients with alcoholic cirrhosis

4 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

The effect of normalization of plasma amino acids on hepatic encephalopathy in man

4 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Kinetics of intravenous administered L-phenylalanine in patients with cirrohosis of the liver

4 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Pathogenesis and therapy of hepatic coma

4 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Tyrosine Metabolism in Patients with Liver Disease*

4 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease

4 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acid analysis in the differential diagnosis of jaundice

4 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Influences of exogenous intake and nitrogen balance on plasma and brain aromatic amino acid concentrations

4 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acid levels of men fed diets differing in protein content. Some observations with valine-deficient diets

4 April 2024

23

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Factors affecting plasma amino acid concentrations in control subjects

4 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

The plasma amino acids in patients with liver failure

4 April 2024

28

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Altered clearance of free amino acids from plasma of patients with cirrhosis of the liver

4 April 2024

29

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Serum amino acid concentrations in alcoholic hepatitis

4 April 2024

30

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma and urinary amino acids in Laennec's cirrhosis

4 April 2024

31

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

4 April 2024

34

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Chronic Hepatitis: To Treat or Not to Treat?

4 April 2024

35

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

The electroencephalograph in liver disease

4 April 2024

37

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution

4 April 2024

38

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy

4 April 2024

39

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Failure of customary treatment in chronic active liver disease: causes and management

4 April 2024

41

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acids: screening, quantitation, and interpretation

4 April 2024

42

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Aminoacid ratios in Reye's syndrome

4 April 2024

43

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

4 April 2024

44

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

The effects L-leucine on the synthesis of urea, glutamate and glutamine by isolated rat liver cells

4 April 2024

45

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Leucine oxidation in diabetes and starvation: Effects of ketone bodies on branched-chain amino acid oxidation in vitro

4 April 2024

46

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions

4 April 2024

48

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

4 April 2024

49

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy

4 April 2024

50

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy

4 April 2024

51

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acid levels in subjects fed isonitrogenous diets containing different proportions of fat and carbohydrate

4 April 2024

52

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Amino acid metabolism during prolonged starvation

4 April 2024

53

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma Amino Acid Levels in Diabetic Ketoacidosis

4 April 2024

54

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Metabolic Changes in Active Chronic Hepatitis

4 April 2024

55

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Plasma amino acids imbalance in patients with liver disease

4 April 2024

57

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Influence of Glucocorticoids on Glucagon Secretion and Plasma Amino Acid Concentrations in Man

4 April 2024

59

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

EFFECT OF SHORT-TERM THERAPY WITH CORTISOL ON THEURINARY EXCRETION OF FREE AMINO ACIDS

4 April 2024

60

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma

4 April 2024

61

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet

4 April 2024

62

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions

4 April 2024

63

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy

4 April 2024

65

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

Amino Acids in Liver Disease: A Cause of Hepatic Encephalopathy?

4 April 2024

67

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy

4 April 2024

68

1 reference

https://api.crossref.org/works/10.1016/0016-5085(81)90486-8

4 April 2024

Identifiers

1 reference